Trade Risk Screening

Pharmaceutical trade compliance,
without manual supplier risk chaos.

Screen suppliers, manufacturers, exporters, logistics providers, directors, and beneficial owners against sanctions, PEP, watchlist, debarment, jurisdiction, and ownership-risk signals — then package the review into an audit-ready case.

Built for compliance teams handling supplier onboarding, import reviews, and pharmaceutical supply-chain risk.

The operational problem

Manual supplier review creates inconsistent decisions and weak audit trails.

Pharmaceutical importers often collect supplier documents manually, check manufacturer names across different sources, review ownership risk separately, and store evidence in spreadsheets or email threads. This creates inconsistent decisions, weak audit trails, and slow supplier onboarding.

Fragmented document collection

Required import documents arrive from different parties at different times. There is no single place to track completeness or attach them to a screening case.

Inconsistent entity checks

Supplier names, manufacturer identities, and beneficial owners are checked inconsistently — or not at all — because the process is manual and there is no structured workflow.

No audit-ready output

When regulators or internal auditors ask what was checked, when, and by whom, the answer is usually buried in email threads and spreadsheet notes.

Screening coverage

What Verifex checks in a pharmaceutical trade case

Every party in the supply chain is a potential risk surface. Verifex screens each one through structured checks and preserves the results as audit evidence.

Supplier and manufacturer names

Screen every counterparty name against sanctions, PEP, watchlist, and debarment sources before contracts or purchase orders are approved.

Exporters, distributors, and logistics providers

Identify all parties in the shipment chain and run each one through the same screening workflow.

Directors and beneficial owners

Trace corporate ownership to identify directors and UBOs, then screen them against PEP and watchlist signals.

Sanctions, PEP, and watchlist exposure

Check every screened party against OFAC, EU, UN, UK, and other configured sanctions and PEP sources.

Debarment and high-risk jurisdiction signals

Flag parties appearing on public debarment lists such as World Bank Debarred and identify high-risk origin or destination jurisdictions.

Uploaded document completeness and evidence trail

Track which required import documents have been uploaded, which are missing, and attach them to the audit case.

Data model

Screening data the workflow can connect

The trade case workflow is designed to support multiple evidence layers. Available sources are active today. Planned sources are on the integration roadmap pending customer validation.

Core screening

Available

Verifex sanctions, watchlist, and PEP screening against 49+ global sources including OFAC, EU, UN, UK, and more.

Customer-uploaded documents

Available

Invoices, contracts, certificates, import permits, and other trade documents uploaded and attached to the case.

Public debarment sources

Available

World Bank Debarred and other public debarment registries as configured sources.

Manual evidence links

Available

Reviewers can attach URLs to public registries, regulatory databases, or other external evidence sources.

Public regulatory evidence

Planned

Public registry and regulatory evidence sources where legally and technically appropriate. Can be attached as manual evidence or configured source.

Licensed PEP, adverse media, and ownership data

Planned

Licensed third-party providers for enhanced PEP coverage, adverse media, and corporate registry data. Available as configured source after customer validation.

Import document checklist

Customer-uploaded documents, tracked in the case.

Verifex does not determine whether a pharmaceutical product is legally approved for import. It helps teams organize documents, extract entities, screen counterparties, and preserve evidence for internal compliance review.

Documents are uploaded by the compliance team, attached to the trade case, and tracked as part of the audit evidence log. Missing documents are flagged. Status is recorded at each review checkpoint.

Document checklist

trade case
  • Sales contract
  • Commercial invoice
  • Certificate of origin
  • Certificate of analysis
  • GMP certificate
  • Product registration proof
  • Import permit
  • Packing list
  • Bill of lading or airway bill
  • Cold-chain / temperature records (where required)
  • Special permits for controlled, potent, toxic, or restricted substances (where applicable)

Workflow

Five steps from supplier contact to audit-ready report.

The workflow supports document-first operations. You do not need a licensed pharma database to start. Core screening and customer-uploaded documents are sufficient for Phase 1.

01

Create a trade case

Start with the importer, supplier, manufacturer, product name, country of origin, and available documents.

02

Extract entities from documents

Capture company names, directors, owners, manufacturers, shipment parties, invoice numbers, batch numbers, and dates.

03

Screen every party

Run suppliers, manufacturers, distributors, logistics providers, directors, and beneficial owners through Verifex screening.

04

Attach public or licensed evidence

Link registry records, debarment data, GMP/GDP evidence, adverse media, or corporate ownership data where available.

05

Generate audit report

Export a structured PDF/JSON report with source links, timestamps, risk results, reviewer notes, and final internal decision.

Risk output

Structured results, not a black-box score.

Each trade case produces a structured risk output showing what was checked, what was found, what is missing, and what requires internal manual review. The final decision always remains with the responsible compliance team.

The example below is illustrative. It shows a realistic output structure — not a guarantee of any specific result.

Example risk output

Illustrative only — not a guarantee of result

risk: medium
SupplierNo sanctions match
ManufacturerRegistry evidence — manual review required
Beneficial ownerPEP possible match — manual review required
Certificate of analysisUploaded
GMP certificateMissing

Internal manual review required. Final decision with responsible compliance team.

API reference

Trade case API endpoints

The pharma trade screening API follows the same REST conventions as the core Verifex screening API. All endpoints require an API key.

Endpoints

POST

/v1/trade/pharma/cases

Create a new trade case

POST

/v1/trade/pharma/cases/:id/entities

Add screened entities to a case

POST

/v1/trade/pharma/cases/:id/documents

Upload or attach a document

POST

/v1/trade/pharma/cases/:id/screen

Run screening on all case entities

GET

/v1/trade/pharma/cases/:id

Retrieve case details and status

GET

/v1/trade/pharma/cases/:id/report

Export structured audit report

Request body

POST /v1/trade/pharma/cases
{
  "importer": {
    "name": "ABC Pharma MMC",
    "country": "AZ"
  },
  "supplier": {
    "name": "Example Medical Trading GmbH",
    "country": "DE"
  },
  "manufacturer": {
    "name": "Example Laboratories GmbH",
    "country": "DE"
  },
  "product": {
    "name": "Example Medicine 500mg",
    "activeIngredient": "Example Ingredient",
    "dosageForm": "tablet",
    "batchNumber": "B-2026-041"
  },
  "documents": [
    "commercial_invoice",
    "certificate_of_origin",
    "certificate_of_analysis",
    "gmp_certificate"
  ]
}

Response

manual_review_required
{
  "caseId": "pharma_case_01J...",
  "status": "manual_review_required",
  "riskLevel": "medium",
  "screening": {
    "supplier": {
      "sanctions": "clear",
      "pep": "clear",
      "watchlist": "clear"
    },
    "manufacturer": {
      "sanctions": "clear",
      "registryEvidence": "needs_manual_review"
    },
    "beneficialOwners": [
      {
        "name": "Example Owner",
        "pep": "possible_match",
        "decision": "manual_review_required"
      }
    ]
  },
  "documents": {
    "commercial_invoice": "uploaded",
    "certificate_of_origin": "uploaded",
    "certificate_of_analysis": "uploaded",
    "gmp_certificate": "missing"
  },
  "audit": {
    "reportAvailable": true,
    "evidenceLogEntries": 8
  }
}

Compliance disclaimer

Verifex does not approve, register, certify, test, inspect, or authorize pharmaceutical products. Verifex is a data and technology layer that helps compliance teams screen counterparties, ownership structures, risk signals, and supporting documents. Final regulatory, legal, import, medical, and commercial decisions remain with the responsible company, regulator, customs authority, qualified professional, or legal advisor.

Get started

Bring supplier risk, documents, and audit evidence into one workflow.

Start with core sanctions screening and customer-uploaded documents. No licensed pharma database required for Phase 1.

Existing Verifex API key works for trade case screening.